SALIX PHARMACEUTICALS LTD

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$286.8M

1,153 transactions

Summary

SALIX PHARMACEUTICALS LTD is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $8.5MSales: $80.4M19 insiders

Date	Insider	Type	Value
2015-04-01	CHAPPELL JOHN F	D	$50.9M
2015-04-01	D ALONZO THOMAS(Acting President and CEO)	U	$12.9M
2015-04-01	Forbes William P(President, Medical, R&D & CDO)	D	$8.9M
2015-04-01	KEANE WILLIAM P	U	$5.7M
2015-04-01	Sirgo Mark A	U	$5.4M
2015-04-01	CHAPPELL JOHN F	D	$5.0M
2015-04-01	Bertrand William C JR(See Remarks)	D	$4.9M
2015-04-01	Scruggs Rick D(Executive Vice President)	U	$4.7M
2015-04-01	CREECH TIMOTHY J(See Remarks)	D	$3.7M
2015-04-01	D ALONZO THOMAS(Acting President and CEO)	D	$3.6M
2015-04-01	D ALONZO THOMAS(Acting President and CEO)	U	$1.8M
2015-04-01	D ALONZO THOMAS(Acting President and CEO)	U	$1.1M
2015-04-01	Sirgo Mark A	D	$1.1M
2015-04-01	KEANE WILLIAM P	D	$1.1M
2015-04-01	CREECH TIMOTHY J(See Remarks)	U	$703K
2015-04-01	Bertrand William C JR(See Remarks)	U	$514K
2015-04-01	D ALONZO THOMAS(Acting President and CEO)	U	$187K
2015-04-01	D ALONZO THOMAS(Acting President and CEO)	U	$45K
2015-04-01	KEANE WILLIAM P	D	—
2015-04-01	D ALONZO THOMAS(Acting President and CEO)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

SALIX PHARMACEUTICALS LTD — Contributions, Lobbying & Contracts | Poliscope